Updated 07:15 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,772.20 -2.38% CL 83.98 -2.36% BTC 64,721.99 -0.26%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,772 −2.38% BTC $64,722 −0.26% VIX 25.46 +11.13% latest tape · as of 07:15 UTC
The Screen · Technology · Communication Equipment

AmpliTech Group, Inc. logoAmpliTech Group, Inc.

AMPG · Nasdaq · USD · Market cap $72M · 46 employees

AmpliTech Group, Inc.

PASS · Titan Ethical · score 94.7
1.95 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price1.95 USD at the 17 Nov 2026 close
  • Fair valueUnder review: only one analyst covers it, too few to cross-check it; our model's value is 2.05x the price, above our 2.00x limit.
  • Our regime readDistribution, as of 16 Nov 2026
  • Ethical screenPasses, score 94.7 out of 100
  • OptionsOpen interest leans heavily to calls (put/call 0.52)
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-17).

Current read
Distribution ?
Screened · screened 2026-11-17
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.52, read 2026-11-15
  • Ethical passes the values gate
Price1.95 USD
Fair valueUnder review
Ethical score94.7/100
Our investment reviews on this name
2026-11-09Read Distribution2.31-15.4% to today ✓Markdown gives way to Distribution after a 32% slide in 7 weeks
2026-09-21Read Markdown3.37-42.1% to today ✓Distribution gives way to Markdown after a 6% slide in 4 weeks
2026-08-21Read Distribution3.57-45.4% to today ✓Markup gives way to Distribution after a 31% slide in 7 weeks
2026-07-02Read Markup5.18-62.4% to today First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

AmpliTech Group, Inc. holds its Distribution at $1.95. The statistical read favours the sellers, held for 44 days.

As held on the ledger · 2026-11-17
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 44 days
Price at the screen$1.95
ValuationN/A trailing · 4.44 forward price to earnings
Values screenPASS · score 94.7
Beta-0.24
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 6.41% Below 33% Interest-bearing debt is just 6.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 7.64% Below 33% Cash held in interest-bearing accounts and securities is 7.6% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 0.64% Below 5% Only 0.6% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

AmpliTech Group, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when AMPG's ethical verdict changes

Today AMPG passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Only one analyst covers it, too few to cross-check it; our model's value is 2.05x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E4.4xvery cheap relative to earnings
EPS, trailing-0.34
EPS, forward0.54
Revenue growth-26.8%revenue is shrinking
Profit margin-33.4%currently unprofitable
Return on equity-19.4%not currently earning a positive return on equity
FCF yield-11.88%
Debt to equity0.08minimal debt: a conservative balance sheet
Current ratio3.76comfortably covers its short-term bills
Beta-0.24barely tracks the market's swings
Short interest, float0.13%
52-week range1.64 - 10.11
MoatWEAK
Market cap$72M
Employees46

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

AMPG trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-16 Distribution $2.25 -2.4% Entry 14

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-11-09 Distribution · changed $2.31 -12.7% Entry 13

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-11-02 Markdown $2.64 +2.9% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-10-26 Markdown $2.57 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-10-19 Markdown $2.57 -9.7% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-10-12 Markdown $2.84 -17.4% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 17.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-10-02 Markdown $3.44 +2.1% Entry 8

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.1% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-09-21 Markdown · changed $3.37 -5.6% Entry 7

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-08-21 Distribution · changed $3.57 -46.2% Entry 6

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 46.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

2026-07-21 Markup $6.64 +28.2% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 28.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 271%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it buy, with a mean price target of $7.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on AMPG

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in AMPG's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · AMPG
DateInsiderTitleTypeSharesValue
2026-01-30 MAQBOOL FAWAD Chief Executive Officer 50,000 $152,000
2026-01-30 SANFRATELLO LOUISA Chief Financial Officer 50,000 $152,000
2026-01-30 FLORES JORGE LUIS Chief Operating Officer 50,000 $152,000
2026-01-14 MAQBOOL FAWAD Chief Executive Officer 500 $2,000
2026-01-14 MAZZIOTA DANIEL RICHARD Director 2,000 $8,000
2026-01-14 FLORES JORGE LUIS Chief Operating Officer 1,000 $4,000
2025-12-18 MODI SHAILESH Director 2,000 $5,800
2025-12-12 LEE ANDREW DYLAN CPA Director 15,000 $46,200
2025-12-12 MAZZIOTA DANIEL RICHARD Director 15,000 $46,200
2025-12-12 MODI SHAILESH Director 15,000 $46,200

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $2.68 +194.8% · $2,948 +194.8%
2 months $1.84 +329.4% · $4,294 +329.4%
3 months $2.52 +213.5% · $3,135 +213.5%
6 months $3.38 +133.7% · $2,337 +133.7%
1 year $2.13 +270.9% · $3,709 +270.9%
2 years $1.12 +605.4% · $7,054 +605.4%
3 years $2.55 +209.8% · $3,098 +209.8%
5 years $5.63 +40.3% · $1,403 +40.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever AMPG does next, these words stay.

AmpliTech Group, Inc. · AMPG · Distribution · $1.95
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.